Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
Abroad (travel likely)RecruitingPHASE2
Conditions
Parkinson Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Institute for Neuroimmune Medicine, Davie, Florida, United States
Contact: Principal Investigator (Irina Rozenfeld, DPN, APRN)Las Mercedes Medical Research, Hialeah, Florida, United States
Contact: Principal Investigator (Frank Alvarez, MD)NextGen Research Group, Miami, Florida, United States
Contact: Study coordinator (Dayana Rojas, PhD, MPH) · dayana.rojas@nextgenresearchgroup.com · 786-427-9659Contact: Study coordinator (Luis Rodriguez) · luis.rodriguez@nextgenresearchgroup.com · (645) 229-4543Charter Research, The Villages, Florida, United States
Contact: Study coordinator (Alessandra Cuevas) · Alessandra.Cuevas@charterresearch.com · 352-441-2000Contact: Principal Investigator (Jeffrey Norton, MD)